Health Canada
- Status: approved
Scalp blocks with ropivacaine and intravenous parecoxib (Scalp blocks with ropivacaine and intravenous parecoxib) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.